This is the first study of changes in protein glycosylation due to exposure of human subjects to ionizing radiation. Site specific glycosylation patterns of 7 major plasma proteins were analyzed; 171 glycoforms were identified; and the abundance of 99 of these was followed in the course of cancer radiotherapy in 10 individual patients. It was found that glycosylation of plasma proteins does change in response to partial body irradiation (~60 Gy), and the effects last during follow-up; the abundance of some glycoforms changed more than twofold. Both the degree of changes and their time-evolution showed large inter-individual variability. 
Introduction
Radiation has been always a very important factor influencing living organisms. Radiation comes from accidental, intentional or natural sources; we can differentiate environmental, industrial, occupational (in wars) radiation, radiological terror and medicinal radiotherapy.
In radiobiology there is an increasing interest in proteomics nowadays [1] [2] [3] . The response for radiation was often studied on the genome level. However DNA damage is only part of the picture; changes in cellular structure; in protein composition of cells and biological fluids are also needed to understand molecular mechanisms and micro-environmental consequences of radiation. Furthermore, radiation may induce changes in higher order organisms. Beside genetics, proteomics may offer new insights, describing new pathophysiological pathways or discovering new biomarker candidates [4] [5] [6] [7] [8] [9] [10] to assess the influence of radiation on living, multicellular organisms. Note, that especially in multicellular organisms, the long-term response of the organism to radiation may even be more important, than radiation damage itself. Cell-cell communication; partly mediated by biological fluids like blood, often involves glycosylation. Bearing these in mind, in the present paper we focus on evaluating long-term glycosylation changes in plasma proteins.
Diversity of proteins and types of molecular pathways they are involved in are enormously expanded due to post-translational modifications. Effects of radiation has already been studied in case of phosphorylation [6, [11] [12] [13] , acetylation [12] , ubiquitination [14] , carbonylation [15, 16] , nitrosylation [15, 16] and glycosylation [17] [18] [19] [20] in different tissues and biofluids and in some cases significant alterations were found.
Glycosylation is one of the most important and most common post-translational modification of proteins. Glycosylation has important biological roles: it takes part in transport of proteins, immune response, communication between cells and several human plasma glycoproteins have been proved to be biomarkers for different diseases [21] [22] [23] [24] . From analytical point of view there are two ways (and combination of these) to characterize glycosylation : 1) Averaging glycosylation data: before analysis glycans are removed from proteins using specific enzymes (e.g.: N-glycans are cleaved with PNGaseF) or acidic hydrolysis, and then released glycan mixture is characterized by the number of antennas and sialic acid residues. In this case important information about attachment sites of glycans is lost. 2) Site-specific glycosylation patterns are carrying more and different biological information: proteins are digested using endoproteases (e.g.: trypsin) and resulted glycopeptides are analyzed, therefore glycosylation sites and site-specific distribution of glycans can also be determined. [25] [26] [27] [28] To our knowledge there are only a few studies published about the relationship between glycosylation and ionizing radiation. 1) Dorsal skin irradiation of mice was performed at different doses (20, 40 and 80 Gy) and serum proteins were analyzed using two dimensional differential in-gel electrophoresis. Glycans were analyzed after they were removed from the proteins using mass spectrometry. Shifts in the isoelectric point (pI) were observed [17, 29] possibly caused by changes in glycosylation, and decrease in biantennary structure, increase in multiantennary N-glycans, outer branch fucosylation and sialylation was found [17] .
However, because averaging glycosylation was studied, there was no information whether changes in glycosylation involved all, or only some specific proteins. 2) In another study [20] mice were exposed to ionizing radiation (0, 3, 6 and 10 Gy) and plasma glycoproteins were analyzed using lectins. Time and dose dependent alterations of glycoproteins containing galactose, N-acetylgalactosamine and mannose were found, however there was no significant difference in the plasma glycoprotein level. 3) In colon cancer cells, correlation between radiation-mediated sialylation of integrin β1 (glycosylated cell surface protein) and increased radio-resistance was observed [18, 19] .
In the current study site-specific glycosylation pattern of plasma proteins was analyzed from human samples. Patients suffering from head and neck cancer were treated with radiotherapy (RT). Site-specific glycosylation pattern was determined from samples collected before, during and after the treatment. We observed that glycosylation of various proteins changed significantly, which may help to better understand the molecular response of the human body for radiation.
Materials and methods

Samples and chemicals
Ten patients (Caucasians; 50-80-year-old, median 61 years; 7 men) with head and neck squamous cell carcinoma (HNSCC) located in larynx (7) or pharynx (3) were enrolled into the study. All patients were subjected to intensity-modulated RT (IMRT) using 6-MV photons.
Total radiation dose delivered to the gross tumor volume (20- All other reagents were purchased from Sigma-Aldrich ® (St. Louis, MO, USA).
Immunoaffinity depletion of plasma samples
To reduce sample complexity, two high abundance proteins: albumin and IgG were removed from human plasma with Agilent Multiple Affinity Removal Spin Cartridge HSA/IgG (Agilent Technologies, Santa Clara, CA, USA).
30 µL plasma sample was loaded onto the cartridge and manufacturer's standard protocol was followed. At the end K 2 HPO 4 and citric acid were added to the diluted samples to prevent aggregation (30-30 mM concentration in the samples), and samples were concentrated with 10 kDa centrifuge filters. After filtration, volume of the depleted plasma sample was 25 µL.
Fractionation of depleted plasma samples
Fractionation of depleted plasma samples was performed using Acquity UPLC ® System (Waters, Milford, MA, USA). Details of this fractionation method and it's benefits during the analysis of glycoproteins was described before [30] .
In-solution digestion
Concentrated fractions were digested as the following: after adding 5 μL NH 4 
nanoLC-MS(/MS) analysis
Digested fractions were analyzed using nanoAcquity UPLC (Waters, Milford, MA, USA) coupled to a high resolution QTOF Premier mass spectrometer (Waters, Milford, MA, USA).
The chromatographic conditions were the following: Symmetry C18 trap column (180 µm i.d. Site-specific glycosylation pattern of the proteins was analyzed by the method described earlier [31] .
Data evaluation
Protein content of the fractions was identified from MS/MS measurements using ProteinLynx 
Results and discussion
The effect of exposure to ionizing radiation on plasma proteins glycosylation was studied for first time in case of human samples. Site-specific glycosylation patterns of 7 abundant plasma proteins were determined in the case of 10 patients. For each patient samples were collected before and after exposure. Pre-treatment sample A was considered as a reference for each In the course of MS/MS studies we have identified altogether 171 glycoforms characterizing the 7 selected proteins. Among these we have selected the 99 glycoforms for a quantitative study (those above the limit of quantification). The list of these components, and their relative abundances in the "reference" pre-treatment sample A, averaged over the 10 patient samples, are shown in Table A . Glycoform abundances vary between the various individuals -the average relative standard deviation (biological variability considering the 10 most intense peaks) is 29%. Reproducibility of individual glycoform abundances (variability of sample preparation and instrumental analysis) is on average 17%, from which reproducibility of instrumental analysis is 8%, using 3-3 replicates. In order to illustrate results and to study the influence of radiotherapy on protein glycosylation, first results for one individual will be discussed. Subsequently we shall look at glycosylation in other individuals to see, how these could be generalized. Table A ) in the course of radiotherapy. In the horizontal axis the change in glycoform abundance during radiotherapy is shown (that compared to its value before radiotherapy started, i.e. abundance measured in sample B compared to that in sample A). This shows the magnitude of change in the various glycoform abundances due to radiotherapy; measured when a large amount of radiation dose was already absorbed by the individual. The vertical axis shows the glycoform abundance one month after radiotherapy finished compared to the abundance before radiotherapy (abundance measured in sample C compared to that in sample A). The figure shows that some glycoforms increased 5-fold, some others decreased 5-fold; most showed smaller changes. In the present pilot study, the limited number of patient samples preclude a general conclusion, which proteins and which glycoforms are most influenced by radiotherapy. This should be established in a subsequent, full scale clinical study. intensity (compared to the respective value before radiotherapy) during and ca. 1 month after radiotherapy are correlated. If the slope is unity, this indicates that radiotherapy induces a certain change; and this change becomes fixed (will not change even one month after treatment). If the slope is zero, this indicates that the change in glycosylation goes back to the "original" value (that before radiotherapy) as soon as radiotherapy is finished. The slope is close to, but less than unity (0.87). This suggest that changes in glycosylation induced by radiotherapy last for a long time. After radiotherapy is finished, protein glycosylation starts to return to the "normal" value (i.e. to that measured before irradiation). The value of the slope suggests, that ca. 87% of radiation-induced changes in glycosylation are still present one month after irradiation was finished. This implies that the effect of radiotherapy on plasma protein glycosylation is likely to last for several months.
The results described above are qualitatively similar to all other persons studied. Some glycoforms increase, some others decrease due to radiotherapy. After irradiation, glycosylation slowly starts to return to "normal". One month after irradiation is finished, the results are somewhere in between that before and during irradiation. One typical example for change in glycosylation can be detected in the case of complement factor H (CFAH), a protein responsible for activation of the alternate pathway of the complement system.
Glycosylation of CFAH shows increased fucosylation on all of its glycosylation sites, but the rates of change are very different for the different sites. The fucosylation change for CFAH glycosylation sites was also observed in liver diseases [33] .
Glycosylation changes are illustrated in one month after radiotherapy, compared to that before). When the value of the blue squares is over unity (i.e. a certain glycoform shows increased abundance due to radiotherapy), there is a high (~ 77%) probability, that the corresponding yellow circle will also be over unity (i.e. the glycoform will have increased abundance even one month after radiotherapy was finished). In an analogous manner, when the value of the blue squares is less than unity (i.e. radiotherapy depletes abundance of a certain glycoform) the orange circle will also be below unity (i.e. will remain depleted for a long time). Note, mainly due to random errors, smaller than ~20% changes in glycoform abundance could not be evaluated.
During the glycosylation analysis of irradiated mice serum samples Chaze et al. [17] observed the decrease of biantennary structures; and increase of tri-tetra-and pentaantennary Nglycans, outer branch fucosylation and sialylation. No difference was measured in the expression of genes involved in the synthesis of biantennary N-glycans, however genes implicated in the multiantennary N-glycan synthesis were found to be overexpressed.
However, Chaze et al. analyzed only removed glycans, therefore information about the proteins containing these glycan structures was lost. Only site-specific glycosylation analysis could give the answer, whether the changes in the intensity of different glycan structures were caused by changes in the abundance of modified proteins with these particular structures or by increases in particular structures linked to different proteins. Note that both in human and in mouse studies a small, few cm 2 surface was irradiated. However, in mouse this represents ca.
10% of body volume (so irradiation can be considered systemic); while in humans it is only ca. 0.01% body volume; so it is clearly localized.
Analyzing site-specific data of all human individuals we observed that intensity of 44% of glycoforms increased and 56% decreased. Correlation between the direction of intensity changes (increasing or decreasing) and the following parameters was studied: a) different proteins, b) different complex sugar types on glycoforms (number of antennas, number of sialic acids and fucoses) and c) different human individuals, but in contrast to the mice samples no correlation was found. This means that the study of site-specific glycosylation pattern is essential in case of human samples for each glycoform of any protein and individual, because from the cleaved mixture of sugars we couldn't recognize the effect of irradiation on glycosylation.
Conclusions
This is the first human study to show that local body irradiation during cancer radiotherapy does change glycosylation of plasma proteins. As glycosylation is involved in various immunological processes and cell-cell communications, this may have impact on efficacy and side effects of radiotherapy. We have studied glycosylation of 7 major plasma proteins in 10 individual cases. In the course of the study we have followed changes in the abundance of 99 glycoforms during radiotherapy. All studied proteins showed glycosylation changes-in most cases 20-30% change in glycoform abundances were observed due to irradiation, although in many cases larger than twofold changes were also found. Note, that these are plasma proteins -i.e. reflect changes in the organism, and not directly related to tissue damage (which occurs in a small body volume only). Compared to other post-translational modification studies these changes can be considered highly significant: in cells after treatment with 10 Gy ionizing radiation only about 1% of quantified phosphoproteins was found to be upregulated more than 2-fold, and about 3.5% were upregulated over 1.5-fold [12] . The results show that radiotherapy changes protein glycosylation for a long period: One month after finishing radiotherapy, the glycosylation profile only starts to return to "normal" (i.e. that before radiotherapy commenced), which indicated long-term effects of radiation. The results suggest that therapeutic radiation induces changes in the whole human body, and these changes last for a long period (several weeks or months). The present experiments showed large interindividual differences. The number of individuals in the present study was insufficient to determine, if glycosylation changes may be used to assess the efficiency of radiotherapy; or the healing capacity of the individual.
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